-
Mashup Score: 0Pivotal CV Trials May Not Apply to Complex Patients - 2 year(s) ago
John Mandrola, MD, interviews Andrew Foy, MD, about his meta-analysis of major cardiovascular trials looking at patients with higher comorbidity burden to see if they experience treatment benefits.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
There was a case of phrenic nerve palsy, which raises a small red flag and will need to be watched in future studies, say experts.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Research at #ACC23/#WCCardio found that use of the PulseSelect ablation system safely & effectively decreased atrial arrhythmia recurrence in patients with paroxysmal #AFib. @michaelTCTMD discusses the latest research on #epAblation in @TCTMD: https://t.co/zTbsA2MTrF
-
-
Mashup Score: 0Racial Disparities in Cardiotoxicity After Chemotherapy - 2 year(s) ago
Black patients with cancer are significantly more likely to experience heart damage following chemotherapy than White patients are, a research review indicates.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
A research review shows Black cancer patients are more likely to experience cardiotoxicity and congestive heart failure related to chemotherapy. https://t.co/k6OtbHImsI #MedTwitter #ACC23 #WCCardio
-
-
Mashup Score: 1ACC Anywhere - Landing page - 2 year(s) ago
ACC Anywhere provides easy access to all of ACC’s video content in one location. You can easily search and browse presentations and watch Collections anytime, anywhere with on demand access. Collection ACCSAP Session Featuring This Year’s CMP Topic Part 1: Test Yourself With Questions on Valvular Heart Disease ACCSAP Session Featuring This Year’s CMP Topic Part 1: Test Yourself With Questions…
Source: accanywhere.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Get on-demand access to #ACC23/#WCCardio's Stump the Chump session where some of the best minds in pediatric & #CHD battle over the toughest congenital case. Hear their thought processes, how they use available data, & more w/ ACC Anywhere. 🔎 https://t.co/MF5pm2jR48 https://t.co/T89qT3DKQj
-
-
Mashup Score: 0Clues to How SGLT2 Inhibitors Work: CAMEO-DAPA - 2 year(s) ago
Ileana Piña, MD, MPH, and Barry A. Borlaug, MD, discuss the CAMEO-DAPA study in patients with HFpEF and potential mechanisms of action for SGLT2 inhibitors.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Ileana Piña, MD, MPH, and Barry A. Borlaug, MD, discuss the CAMEO-DAPA study in patients with HFpEF and potential mechanisms of action for SGLT2 inhibitors. #ACC23 #WCCardio https://t.co/AAHGveWuh4
-
-
Mashup Score: 2Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals - 2 year(s) ago
This cohort study assesses quality of care and clinical outcomes for US patients hospitalized for heart failure at rural vs urban hospitals in the Get With The Guidelines–Heart Failure registry.
Source: jamanetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In this cohort study from @AHA_Research #GWTG_HF, patients hospitalized for #HF at rural hospitals are less likely to receive guideline therapies, but have similar in-hospital and 30-day outcomes. https://t.co/ryT3KctJxr @SJGreene_md @DCRINews #ACC23 #WCCardio
-
-
Mashup Score: 4
This case report describes a patient in their 60s with shortness of breath who tested positive for COVID-19.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This case report describes a patient in their 60s with shortness of breath who tested positive for COVID-19. #ACC23 #WCCardio https://t.co/IviZCrk39g
-
-
Mashup Score: 5Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUT - 2 year(s) ago
The 3-year results show that low-surgical-risk patients undergoing aortic valve replacement continue to show lower rates of all-cause mortality and disabling stroke with TAVR compared with surgery.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
“The results provide a little more reassurance…that will go a little way further," #JACCINT Editor-in-Chief Dr. David Moliterno commented on the 3-year results from the Evolut trial at #ACC23/#WCCardio. Read more in @Medscape: https://t.co/jDT7t3YMJs @JACCJournals #TAVR
-
-
Mashup Score: 0Even Vigorous Exercise Appears Safe for HCM Patients: LIVE-HCM - 2 year(s) ago
Patients with hypertrophic cardiomyopathy should no longer be routinely saddled with restriction from intense exercise or sports, which don’t add to their arrhythmic risk, a large study suggests.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The message of the LIVE-HCM study at #ACC23/#WCCardio "will be that everyone needs to exercise, and that at whatever level you want to do it, it's relatively low risk,” said #ACCSportsCardio Immediate Past Chair Dr. @eugenechung01. Read more in @Medscape: https://t.co/6JZZhQseek
-
-
Mashup Score: 0COORDINATEd Effort Boosts Optimal Therapy - 2 year(s) ago
Cardiology clinics receiving educational and advisory guidance improved their treatment of patients with type 2 diabetes and atherosclerotic disease.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
"A particular strength of this study was its simple design. All the interventions are low-tech and scalable," #ACCCVT member @KristenPharmD commented on the COORDINATE-Diabetes trial at #ACC23/#WCCardio. https://t.co/btjnyGA5R9 #Diabetes
-
.@drjohnm interviews @AndrewFoy82 about his meta-analysis of major cardiovascular trials looking at patients with higher comorbidity burden to see if they experience treatment benefits. #ACC23 #WCCardio #CardioTwitter https://t.co/93prjzUaLP